Treatment with Ivermectin Increases the Population of Bifidobacterium in the Gut

Hazan et al., ACG 2023, Oct 2023

Probiotics for COVID-19

19th treatment shown to reduce risk in March 2021, now with p = 0.00000044 from 29 studies.

Lower risk for mortality, hospitalization, progression, recovery, and cases.

No treatment is 100% effective. Protocols combine treatments.

6,300+ studies for 210+ treatments. c19early.org

Meta Analysis

Analysis of the effect of ivermectin on the gut microbiome, showing a significant increase in Bifidobacterium.

Bifidobacterium plays a key role in the immune system, for example enhancing antibody production, facilitating the induction of regulatory T cells, modulating the immune response of macrophages, dendritic cells, and T cells, maintaining gut barrier integrity, and inhibiting harmful microbes.

Increased Bifidobacterium is associated with lower COVID-19 severity1.

Probiotic efficacy depends on the specific strains used. Specific microbes may decrease or increase COVID-19 risk2.

Important missing comments or errors? Let us know.

Study covers probiotics and ivermectin.

1. Taufer et al., The Role of Bifidobacterium in COVID-19: A Systematic Review, Life, doi:10.3390/life13091847.mdpi.com, doi.org.

2. Li et al., Large-scale genetic correlation studies explore the causal relationship and potential mechanism between gut microbiota and COVID-19-associated risks, BMC Microbiology, doi:10.1186/s12866-024-03423-0.biomedcentral.com, doi.org.

Hazan et al., 22 Oct 2023, preprint, 4 authors.